Cargando…
HDAC Inhibitor Sodium Butyrate Attenuates the DNA Repair in Transformed but Not in Normal Fibroblasts
Many cancer therapy strategies cause DNA damage leading to the death of tumor cells. The DNA damage response (DDR) modulators are considered as promising candidates for use in combination therapy to enhance the efficacy of DNA-damage-mediated cancer treatment. The inhibitors of histone deacetylases...
Autores principales: | Gnedina, Olga O., Morshneva, Alisa V., Skvortsova, Elena V., Igotti, Maria V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998589/ https://www.ncbi.nlm.nih.gov/pubmed/35408878 http://dx.doi.org/10.3390/ijms23073517 |
Ejemplares similares
-
Sodium Butyrate Enhances the Cytotoxic Effect of Etoposide in HDACi-Sensitive and HDACi-Resistant Transformed Cells
por: Gnedina, Olga O., et al.
Publicado: (2023) -
Time-dependent modulation of FoxO activity by HDAC inhibitor in oncogene-transformed E1A+Ras cells
por: Morshneva, Alisa, et al.
Publicado: (2018) -
Correction: Time-dependent modulation of FoxO activity by HDAC inhibitor in oncogene-transformed E1A+Ras cells
por: Morshneva, Alisa, et al.
Publicado: (2018) -
Expression of Adenoviral E1A in Transformed Cells as an Additional Factor of HDACi-Dependent FoxO Regulation
por: Morshneva, Alisa, et al.
Publicado: (2019) -
Ras Participates in the Regulation of the Stability of Adenoviral Protein E1A via MAP-kinase ERK
por: Morshneva, A. V., et al.
Publicado: (2022)